WEST PHARMACEUTICAL SERVICES, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $228.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $228.30M, a 6.20% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $243.40M, a 34.11% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $369.40M, a 6.34% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $394.40M, a 6.10% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $228.30M 10-K · filed 2026-02-17 |
| 2024-12-31 | $243.40M 10-K · filed 2026-02-17 |
| 2023-12-31 | $369.40M 10-K · filed 2026-02-17 |
| 2022-12-31 | $394.40M 10-K · filed 2025-02-18 |
| 2021-12-31 | $420.00M 10-K · filed 2024-02-20 |
| 2020-12-31 | $227.00M 10-K · filed 2023-02-21 |
| 2019-12-31 | $161.20M 10-K · filed 2022-02-22 |
| 2018-12-31 | $132.90M 10-K · filed 2021-02-23 |
| 2017-12-31 | $96.50M 10-K · filed 2020-02-24 |
| 2016-12-31 | $84.50M 10-K · filed 2019-02-28 |
| 2015-12-31 | -$4.00M 10-K · filed 2018-02-26 |
| 2014-12-31 | $57.50M 10-K · filed 2017-02-28 |
| 2013-12-31 | $28.90M 10-K · filed 2016-02-26 |
| 2012-12-31 | $8.90M 10-K · filed 2015-02-25 |
| 2011-12-31 | $15.80M 10-K · filed 2014-02-27 |
| 2010-12-31 | $7.20M 10-K · filed 2013-02-27 |
| 2009-12-31 | $6.50M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |